文献速递头颈外科

甲状腺滤泡癌的手术范围

Extent of Surgery for Follicular Thyroid Carcinoma.
PubMed 文献 · Laryngoscope · 2022-11-01

基于美国国家癌症数据库2004至2015年数据的回顾性分析,纳入6871例肿瘤1-4厘米的甲状腺滤泡癌患者,比较腺叶切除与甲状腺全切或近全切的总体生存。腺叶切除组1507例,甲状腺全切组5364例,5年总体生存率分别为96%与95.5%,差异无统计学意义(P=0.08),按肿瘤分级分层后亦无显著差异。

要点

  • 甲状腺滤泡癌肿瘤1-4厘米患者中,腺叶切除与甲状腺全切的5年总体生存率分别为96%与95.5%,差异无统计学意义(P=0.08)。
  • 腺叶切除组平均生存12.94年,甲状腺全切组平均生存12.71年。
  • 按肿瘤分级分层后,腺叶切除与甲状腺全切之间生存无显著差异。

核心结论

  • 甲状腺滤泡癌患者接受更广泛切除(甲状腺全切或近全切)与腺叶切除相比,生存时间无显著差异。

研究设计与样本

  • 研究为对美国国家癌症数据库(NCDB)的回顾性分析。
  • 纳入2004至2015年因甲状腺滤泡癌接受手术、年龄>18岁、肿瘤大小1-4厘米、无其他恶性肿瘤且随访时间>0的患者。
  • 共纳入6871例患者,其中腺叶切除(≥1叶切除)1507例,甲状腺全切或近全切5364例。
  • 采用Pearson卡方检验比较队列,Kaplan-Meier生存分析和Cox风险模型评估总体生存,P<0.05为显著。

主要发现

  • 腺叶切除组与甲状腺全切组在患者人口学特征、合并症指数、局部扩散或肿瘤分级方面无显著差异。
  • 腺叶切除组平均生存12.94年,甲状腺全切组平均生存12.71年。
  • 手术范围与生存无显著差异:腺叶切除5年总体生存率96%,甲状腺全切5年总体生存率95.5%,P=0.08。
  • 按肿瘤分级分层后,腺叶切除与甲状腺全切之间生存无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To examine the association between the extent of surgery and overall survival in follicular thyroid cancer (FTC) patients. STUDY DESIGN: Retrospective analysis of the National Cancer Database (NCDB). METHODS: Patients who underwent surgical intervention for FTC from 2004 to 2015 were selected. Patients were >18 years old, with tumor size 1-4 cm, no other malignancies, and >0 follow up time. Patients were divided into two cohorts based on extent of surgery: lobectomy (≥1 lobe resected) and thyroidectomy (total or near total resection). Pearson's chi-squared analysis was used to compare cohorts. Kaplan-Meier survival and Cox hazards models were utilized to determine overall survival between two cohorts with p < 0.05 used for significance. RESULTS: A total of 6871 patients were identified with FTC, of which 1507 patients underwent lobectomy and 5364 patients underwent total thyroidectomy. There were no significant differences in patient demographics, comorbidity index, local spread, or tumor grade. Patients undergoing lobectomy had mean survival of 12.94 versus 12.71 years for those undergoing thyroidectomy. Extent of surgery was not associated with a significant difference in survival (5 years OS = 96% in lobectomy and 95.5% in total thyroidectomy, p = 0.08). Stratification by tumor grade resulted in no significant difference in survival between lobectomy and thyroidectomy. CONCLUSION: Survival time was not significantly different in patients with more extensive resection of FTC. LEVEL OF EVIDENCE: 3 Laryngoscope, 133:993-999, 2023.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Kethidi N, Vedula S, Shihora D, et al. Extent of Surgery for Follicular Thyroid Carcinoma. Laryngoscope. 2022. PMID: 36317788. doi:10.1002/lary.30441

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。